Yıl: 2013 Cilt: 14 Sayı: 2 Sayfa Aralığı: 81 - 86 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model

Öz:
Amaç: Ooferektomize sıçan endometriozis modelinde melatoninin endometriotik odaklar üzerine etkisini incelemeyi amaçladık Gereç ve Yöntemler: Bu çalışma prospektif, randomize, kontrollü, deneysel bir çalışmadır. Çalışma Yeditepe Üniversitesi Deneysel Araştırma Merkezinde (YÜDETAM) yapıldı. Deneysel çalışmamıza 22 adet dişi, gebe olmayan, nulligravid Spraque-Dawley albino sıçan dahil edildi. Ooferektomize edilen sıçanlarda cerrahi olarak endometriozis oluşturuldu. Sıçanlar iki gruba ayrıldı: kontrol grubu ve melatonin grubu. Melatonin grubunda 2 hafta boyunca sıçanlara melatonin (20 mg/ kg/gün) tedavisi verildi. Endometriotik regresyonu değerlendirmek için operasyonlar yapıldıktan sonra melatonin tedavisi sonlandırıldı. Rekürrens oranlarını değerlendirmek için altıncı haftanın sonunda nekropsiler yapıldı. Endometriotik odakların hacim ve histopatolojik skorları değerlendirildi. Bulgular: Endometriotik lezyonların hacimleri melatonin grubunda anlamlı derecede azaldı. Ayrıca, melatonin grubu kendi içerisinde incelendiğinde endometriotik lezyonların hacimlerinin anlamlı derecede azaldı ve histopatolojik skorları anlamlı derecede arttı. Sonuç: Melatonin sıçanlarda endometriotik odakların gerilemesine ve histopatolojik skorların iyileşmesine neden olur. (J Turkish-German Gynecol Assoc 2013; 14: 81-6)
Anahtar Kelime:

Konular: Kadın Hastalıkları ve Doğum

Melatonin tedavisi ooferektomize sıçanlar endometriozis modelinde endometriotik odaklarda gerilemeye yol açar

Öz:
Objective: We aimed to determine the effects of melatonin treatment on endometrial implants in an oopherectomized rat endomeriosis model.Material and Methods: This study is a prospective, randomised,controlled experimental study. It was carried out at the Experimenal Research Center of Yeditepe University (YUDETAM). Twenty-two,emale, non-pregnant, nulligravid Spraque-Dawley albino rats werencluded in our study. Endometriosis was surgically induced in oopherectomized rats. Rats were randomised into two groups: controlgroup and melatonin group. In the melatonin group, rats were treatedwith melatonin (20 mg/kg/day) for two weeks. After the operationswere performed to assess the regression of the endometriotic lesions,melatonin treatment was stopped. At the end of the sixth week nec-ropsies were performed to assess the rate of recurrence. The volumeand histopathological scores of endometriotic foci were examined.Results: Volumes of the endometriotic lesions significantly decreased in the melatonin group. Also, when the melatonin group wasanalysed within itself, endometriotic lesion volumes decreased andhistopathological scores increased significantly.Conclusion: Melatonin causes regression of the endometriotic lesions in rats and improvement in their histopathological scores.(J Turkish-German Gynecol Assoc 2013; 14: 81-6)
Anahtar Kelime:

Konular: Kadın Hastalıkları ve Doğum
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Olive DL, Schwartz LB. Endometriosis. N Engl J Med 1993; 328: 1759-69.
  • Witz CA. Current concepts in the pathogenesis of endometriosis. Clin Obstet Gynecol 1999; 42: 566-85.
  • Sampson JA. Peritoneal endometriosis due to the menstrual dis- semination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-69.
  • Blumenkrantz MJ, Gallagher N, Bashore RA, Tenckhoff H. Retrograde menstruation in women undergoing chronic peritoneal dialysis. Obstet Gynecol 1981; 57: 667-70.
  • Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometrio- sis. Obstet Gynecol 1984; 64: 151-4.
  • Houston DE, Noller KL, Melton LJ 3rd, Selwyn BJ, Hardy RJ. Incidence of pelvic endometriosis in Rochester, Minnesota, 1970- 1979. Am J Epidemiol 1987; 125: 959-69.
  • Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health 1996; 86: 195-9.
  • Berkkanoglu M, Arici A. Immunology and endometriosis. Am J Reprod Immunol 2003; 50: 48-59.
  • Gupta S, Agarwal A, Krajcir N, Alvarez JG. Role of oxidative stress in endometriosis. Reprod Biomed Online 2006; 13: 126-34.
  • Van Langendonckt A, Casanas-Roux F, Donnez J. Iron overload in the peritoneal cavity of women with pelvic endometriosis. Fertil Steril 2002; 78: 712-8.
  • Ota H, Igarashi S, Hatazawa J, Tanaka T. Immunohistochemical assessment of superoxide dismutase expression in the endome- trium in endometriosis and adenomyosis. Fertil Steril 1999; 72: 129-34.
  • Ota H, Igarashi S, Kato N, Tanaka T. Aberrant expression of glutathi- one peroxidase in eutopic and ectopic endometrium in endome- triosis and adenomyosis. Fertil Steril 2000; 74: 313-8.
  • Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 2003; 79: 1288-93.
  • Polak G, Koziol-Montewka M, Gogacz M, Tarkowski R, Kotarski J. Total antioxidant status of peritoneal fluid in infertile women. Europ J Obstet Gynecol Reprod Biol 2001; 94: 261-3.
  • Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121-5.
  • Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal- Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
  • Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 151-60.
  • Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 1997; 3: 27-45.
  • Sillem M, Prifti S, Neher M, Runnebaum B. Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis. Hum Reprod Update 1998; 4: 730-5.
  • Collette T, Maheux R, Mailloux J, Akoum A. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Hum Reprod 2006; 21: 3059-67.
  • Cox KE, Piva M, Sharpe-Timms KL. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod 2001; 65: 1297-303.
  • Uzan C, Cortez A, Dufournet C, Fauvet R, Siffroi JP, Daraï E. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases -2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2. Virchows Arch 2004; 445: 603-9.
  • Pustovrh MC, Jawerbaum A, Capobianco E, White V, Martínez N, López-Costa JJ, et al. Oxidative stress promotes the increase of matrix metalloproteinases-2 and -9 activities in the feto-placental unit of diabetic rats. Free Radic Res 2005; 39: 1285-93.
  • Mori K, Shibanuma M, Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 2004; 64: 7464-72.
  • Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-9.
  • Arumugam K, Yip YC. De novo formation of adhesions in endome- triosis: the role of iron and free radical reactions. Fertil Steril 1995; 64: 62-4.
  • Alpay Z, Saed GM, Diamond MP. Female infertility and free radi- cals: potential role in adhesions and endometriosis. J Soc Gynecol Invest 2006; 13: 390-8.
  • Portz DM, Elkins TE, White R, Warren J, Adadevoh S, Randolph J. Oxygen free radicals and pelvic adhesion formation: I. Blocking oxygen free radical toxicity to prevent adhesion formation in an endometriosis model. Int J Fertil 1991; 36: 39-42.
  • Arendt J, Melatonin and the mammalian pineal gland, Chapman & Hall, London, 1995.
  • Pevet P, Bothorel B, Slotten H, Saboureau M. The chronobiotic properties of melatonin. Cell Tissue Res 2002; 309: 183-91.
  • Reiter RJ, Tan DX, Maldonado MD. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 2005; 39: 215-6.
  • Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad-spectrum antioxidant and free radical scav- enger. Curr Top Med Chem 2002; 2: 181-97.
  • Reiter RJ, Calvo JR, Karbownik M, QiW, Tan DX. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 2000; 917: 376-86.
  • Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Reiter RJ, Swarnakar S. Role of melatonin in regulating matrix metallopro- teinase-9 via tissue inhibitors of metalloproteinase-1 during protec- tion against endometriosis. J Pineal Res 2008; 44: 439-49.
  • Yildirim G, Attar R, Ozkan F, Kumbak B, Ficicioglu C, Yesildaglar N. The effects of letrozole and melatonin on surgically induced endo- metriosis in a rat model: a preliminary study. Fertil Steril 2010; 93: 1787-92.
  • Demirbag S, Cetinkursun S, Tasdemir U, Ozturk H, Pekcan M, Yesildaglar N. Comparison of hyaluronate/carboxymethylcellulose membrane and ME for prevention of adhesion formation in a rat model. Hum Reprod 2005; 20: 2021-4.
  • Attar R, Yildirim G, Kumbak B, Fıçıcıoglu C, Demirbag S, Yesildaglar N. Efficacy of melatonin and hyaluronate/carboxymethylcellulose membrane in preventing adhesion re-formation following adhe- siolysis in the rat uterine model. J Obstet Gynaecol Res 2011; 37: 125-31.
  • Vernon MW, Wilson EA. Studies on the surgical induction of endo- metriosis in the rat. Fertil Steril 1985; 44: 684-94.
  • Lebovic DI, Kir M, Casey CL. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril 2004; 82: 1008-13.
  • Uygur D, Aytan H, Zergeroglu S, Batioglu S. Leflunomide—an immu- nomodulator induces regression of endometrial explants in a rat model of endometriosis. J Soc Gynecol Investig 2006; 13: 378-83.
  • Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudleb MR, Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 1999; 72: 135-41.
  • Ballweg M. Impact of endometriosis on women’s health: compara- tive historical data show that the earlier the onset, the more severe the disease. Best Pract Res Clin Obstet Gynecol 2009; 18: 201-18.
  • Simoens S, Hummelshoj L, D’Hooghe T. Endometriosis: cost esti- mates and methodological perspective. Hum Reprod Update 2007; 13: 394-404.
  • Soares SR, Martínez-Varea A, Hidalgo-Mora JJ, Pellicer A. Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril 2012; 98: 529-55.
  • Hughes E, FedorkowD, Collins J, Vandekerckhove P. Ovulation sup- pression for endometriosis. Cochrane Database Syst Rev 2003; 3: CD000155.
  • Koc O, Gunduz B, Topcuoglu A, Bugdayci G, Yilmaz F, Duran B. Effects of pinealectomy and melatonin supplementation on endo- metrial explants in a rat model. Eur J Obstet Gynecol Reprod Biol 2010; 153: 72-6.
  • Guney M, Oral B, Karahan N, Mungan T. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril 2008; 89: 934-42.
  • Paul S, Bhattacharya P, Das Mahapatra P, Swarnakar S. Melatonin protects against endometriosis via regulation of matrix metallopro- teinase-3 and an apoptotic pathway. J Pineal Res 2010; 49: 156-68.
  • Yesildaglar N, Yildirim G, Attar R, Karateke A, Ficicioglu C, Yilmaz B. Exposure to industrially polluted water resulted in regressed endometriotic lesions and enhanced adhesion formation in a rat endometriosis model: a preliminary study. Fertil Steril 2010; 93: 1722-4.
APA KOCADAL ÇETİNKAYA N, Attar R, YILDIRIM G, FIÇICIOĞLU C, YEŞİLDAĞLAR N, ÖZKAN F, YILMAZ B (2013). Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. , 81 - 86.
Chicago KOCADAL ÇETİNKAYA Nilüfer,Attar Rukset,YILDIRIM Gazi,FIÇICIOĞLU Cem,YEŞİLDAĞLAR Narter,ÖZKAN Ferda,YILMAZ Bayram Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. (2013): 81 - 86.
MLA KOCADAL ÇETİNKAYA Nilüfer,Attar Rukset,YILDIRIM Gazi,FIÇICIOĞLU Cem,YEŞİLDAĞLAR Narter,ÖZKAN Ferda,YILMAZ Bayram Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. , 2013, ss.81 - 86.
AMA KOCADAL ÇETİNKAYA N,Attar R,YILDIRIM G,FIÇICIOĞLU C,YEŞİLDAĞLAR N,ÖZKAN F,YILMAZ B Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. . 2013; 81 - 86.
Vancouver KOCADAL ÇETİNKAYA N,Attar R,YILDIRIM G,FIÇICIOĞLU C,YEŞİLDAĞLAR N,ÖZKAN F,YILMAZ B Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. . 2013; 81 - 86.
IEEE KOCADAL ÇETİNKAYA N,Attar R,YILDIRIM G,FIÇICIOĞLU C,YEŞİLDAĞLAR N,ÖZKAN F,YILMAZ B "Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model." , ss.81 - 86, 2013.
ISNAD KOCADAL ÇETİNKAYA, Nilüfer vd. "Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model". (2013), 81-86.
APA KOCADAL ÇETİNKAYA N, Attar R, YILDIRIM G, FIÇICIOĞLU C, YEŞİLDAĞLAR N, ÖZKAN F, YILMAZ B (2013). Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. Journal of the Turkish-German Gynecological Association, 14(2), 81 - 86.
Chicago KOCADAL ÇETİNKAYA Nilüfer,Attar Rukset,YILDIRIM Gazi,FIÇICIOĞLU Cem,YEŞİLDAĞLAR Narter,ÖZKAN Ferda,YILMAZ Bayram Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. Journal of the Turkish-German Gynecological Association 14, no.2 (2013): 81 - 86.
MLA KOCADAL ÇETİNKAYA Nilüfer,Attar Rukset,YILDIRIM Gazi,FIÇICIOĞLU Cem,YEŞİLDAĞLAR Narter,ÖZKAN Ferda,YILMAZ Bayram Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. Journal of the Turkish-German Gynecological Association, vol.14, no.2, 2013, ss.81 - 86.
AMA KOCADAL ÇETİNKAYA N,Attar R,YILDIRIM G,FIÇICIOĞLU C,YEŞİLDAĞLAR N,ÖZKAN F,YILMAZ B Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. Journal of the Turkish-German Gynecological Association. 2013; 14(2): 81 - 86.
Vancouver KOCADAL ÇETİNKAYA N,Attar R,YILDIRIM G,FIÇICIOĞLU C,YEŞİLDAĞLAR N,ÖZKAN F,YILMAZ B Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. Journal of the Turkish-German Gynecological Association. 2013; 14(2): 81 - 86.
IEEE KOCADAL ÇETİNKAYA N,Attar R,YILDIRIM G,FIÇICIOĞLU C,YEŞİLDAĞLAR N,ÖZKAN F,YILMAZ B "Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model." Journal of the Turkish-German Gynecological Association, 14, ss.81 - 86, 2013.
ISNAD KOCADAL ÇETİNKAYA, Nilüfer vd. "Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model". Journal of the Turkish-German Gynecological Association 14/2 (2013), 81-86.